Annual Drug Patent Expirations for AXUMIN
Axumin is a drug marketed by Blue Earth and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has twenty-seven patent family members in sixteen countries.
The generic ingredient in AXUMIN is fluciclovine f-18. One supplier is listed for this compound. Additional details are available on the fluciclovine f-18 profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
